Arrowstreet Capital’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Sell |
98,963
-2,298
| -2% | -$14K | ﹤0.01% | 1710 |
|
|
2025
Q1 | $770K | Sell |
101,261
-261,220
| -72% | -$1.99M | ﹤0.01% | 1530 |
|
|
2024
Q4 | $3.49M | Buy |
362,481
+300,433
| +484% | +$2.89M | ﹤0.01% | 1120 |
|
|
2024
Q3 | $367K | Sell |
62,048
-841,096
| -93% | -$4.97M | ﹤0.01% | 1566 |
|
|
2024
Q2 | $6.26M | Sell |
903,144
-27,005
| -3% | -$187K | 0.01% | 770 |
|
|
2024
Q1 | $7.16M | Buy |
930,149
+7,554
| +0.8% | +$58.2K | 0.01% | 786 |
|
|
2023
Q4 | $8.09M | Buy |
922,595
+254,032
| +38% | +$2.23M | 0.01% | 614 |
|
|
2023
Q3 | $4.87M | Buy |
668,563
+444,072
| +198% | +$3.24M | 0.01% | 663 |
|
|
2023
Q2 | $1.48M | Buy |
+224,491
| New | +$1.48M | ﹤0.01% | 900 |
|
|
2021
Q1 | – | Sell |
-457,760
| Closed | -$4.16M | – | 2411 |
|
|
2020
Q4 | $4.16M | Buy |
+457,760
| New | +$4.16M | 0.01% | 1281 |
|
|
2018
Q4 | – | Sell |
-1,377,884
| Closed | -$8.52M | – | 1439 |
|
|
2018
Q3 | $8.52M | Sell |
1,377,884
-293,160
| -18% | -$1.81M | 0.02% | 440 |
|
|
2018
Q2 | $10.7M | Sell |
1,671,044
-55,511
| -3% | -$355K | 0.03% | 405 |
|
|
2018
Q1 | $12M | Buy |
1,726,555
+1,093,038
| +173% | +$7.62M | 0.03% | 407 |
|
|
2017
Q4 | $7.99M | Buy |
633,517
+360,717
| +132% | +$4.55M | 0.02% | 502 |
|
|
2017
Q3 | $3.24M | Buy |
272,800
+262,300
| +2,498% | +$3.11M | 0.01% | 581 |
|
|
2017
Q2 | $157K | Buy |
+10,500
| New | +$157K | ﹤0.01% | 1013 |
|